Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent hehehe. They don't want eyes on this yet. Confirms my suspicion. Pretty sure we're on a good one here. Going to be oppurtunity for all players short, long and flippers. Love it. Stick around folks timing is everything.
Understatement-something HUGE happening. Will be preferred method of drug delivery by medical professionals.
IMO Seems price has to go up, or there will be a shortage of shares especially with there being a cap on percentage of shares that can be owned by note holders. Either way price will go up eventually IMO. Easy money here. If they over issue shares for noteholders, they will cancel those shares at expense to noteholders. That's why it's in everyone's interest to have an increase in pps. If not then just digging hole deeper and deeper. Which won't be bad either cause we will continue to buy cheapies to help dig that hole;) then they will pay pay pay
I have a good feeling about this one. WOFA is $$$$
Yeah, that's what im saying. If FDA approves device, happy-happy!
We go on from there to next issues at hand. All negative postings about ADMD are moot. The focus is on the device. That's all.
Listen......, human trials for this device are implied. This device will work safely or not. That's all that matters. The device was created to deliver y90 gel safely to the patient. It must also be safe for the medical staff that will use/handle the device.. This is what is under review with the FDA. The efficacy of the y90 gel is a completely different issue. Of course there will be all kinds of human trials in the future. first we must create a device to safely use the y90 gel in trials and that's what is happening here and now. All the other chatter is moot. The device must happen 1st. $$ADMD$$
Nonsense. Its a medical device not a drug. It will work or it won't. FDA animal rule will apply.
yes it is updated, excited for this one, for i still find LINK on this list which makes me believe these shares have great value ---
http://pcaobus.org/About/Ops/Documents/Support%20Fee/Issuers_Paid.pdf
goto page 83.
Which issuers are subject to the PCAOB and Financial Accounting Standards Board ("FASB")[2] issuer accounting support fees?
All companies that are issuers, as that term is defined in Section 2(a)(7) of the Sarbanes-Oxley Act of 2002, as amended ("Act"), as of the date on which the allocation of the annual PCAOB and FASB issuer accounting support fees are set are subject to the issuer accounting support fees. Generally, Equity Issuers and Investment Company Issuers described below are assessed shares of the issuer accounting support fees greater than $0:
Equity Issuers: Publicly-traded companies with average, monthly equity market capitalization during the preceding calendar year of greater than $75 million based on all classes of common equity.
Investment Company Issuers: Entities registered under Section 8 of the Investment Company Act of 1940 and issuers that have elected to be regulated as business development companies pursuant to Section 54 of the Investment Company Act of 1940 with average, monthly market capitalization or net asset value during the preceding calendar year of greater than $500 million.
The Board uses market capitalization and net asset value information from nationally-recognized market data sources
http://pcaobus.org/About/Ops/Pages/SupportFeeFAQ.aspx
i also found that Link Energy is part of the Tactex F1 private equity fund lp.
notice the same domain name registrant name is also found here-http://www.energychoicematters.com/stories/20140717a.html
If ADMD stock were a golf ball, and $0.01 were the hole,-this is how this stock been making me feel-
MMs just rocking the cradle trying to shake shares while ther straddle bets are at an impass
ADMD 2 billion A/S bigger than RCHA with 37 billion A/S no joke- Battelle, potential partnership with C.R.Bard(NYSE)BCR, etc.. plans in place for global markets-ADMD much larger demographic for medical device than RCHA has for drug.
http://www.isotopeworld.com/about-us/industry-partners/
http://www.isotopeworld.com/about-us/awards-recognition/
"I dont think there will be too much funny business with this stock because"------
ADMD's CFO-Forensic Accountant,Certified Fraud Examiners
Leonard Bruce Jolliff
Chief Financial Officer
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMIC’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
less than 6 grand in trading activity has moved the stock 14 percent, should be getting near some good price movement here
my whole bet here with lehman i feel prety good about, still have preferred shares in OBS. not sure how i feel about cts. these ct trust guarantee seem to hinge on trusts' ability to distribute funds- if the trust have funds available for distribution. idk, the cts were entities created out of inter-company debt and could be forgiven-so no funds for distribution as we were told in guarantee SMANP is a ct trust that isnt even BK but still trades and i dont think that guarantee is being enforced. company cts are attractive for tax treatment and higher yielding divis but i dont think guarantees that strong. another example bk7 Anthracite Capital (blackrock). please enlighten me if off basis or me thinking screwy
total over the last three trading sessions ADMD short volume under 10 million shares with volume of 106 million shares. lets see if short volume continues to dwindle-
strange thing in my account when going over taxes is that they have a value for lehpq as an unrealized loss? but the lehjq are at zero value. wonder why when you cannot sell either the j's or p's . why only the p's and not the j's- anyone else notice this? just so no one bothers asking-the lehpq's value is my cost basis for the p's and not value of p's. tia
thanks JOVI- i have only received a couple things in the mail regarding lehman over these last few years. nothing i had to act on, but no mail this last year and half or two.
thanks i have preferred in the OBS
question for the board- did any of you OBS holders have to file any type of claim or did trustee do it for benefit of OBS holders-thanks in advance
Off-Balance Sheet Financing
http://www.riskglossary.com/link/off_balance_sheet_finance.htm
Explained:
off-balance sheet financing
on-balance sheet financing
pass-through
special purpose entity
special purpose vehicle
On-balance sheet financing is any form of direct debt or equity funding of a firm. If the funding is equity, it appears on the firm's balance sheet as owners equity. If it is debt, it appears on the balance sheet as a liability. Any asset the firm acquires with the funding also appears on the balance sheet.
Off-balance sheet financing, by comparison, is any form of funding that avoids placing owners' equity, liabilities or assets on a firm's balance sheet. This is generally accomplished by placing those items on some other entity's balance sheet.
A standard approach is to form a special purpose vehicle (SPV) and place assets and liabilities on its balance sheet. Also called a special purpose entity (SPE), an SPV is a firm or legal entity established to perform some narrowly-defined or temporary purpose. The sponsoring firm accomplishes that purpose without having to carry any of the associated assets or liabilities on its own balance sheet. The purpose is achieved "off-balance sheet."
Under most accounting regimes, if a sponsoring firm wholly owns an SPV, the SPV's balance sheets is consolidated into its own. Rather than have the SPV appear on its balance sheet as an asset, the sponsoring firm has all the SPV's individual assets and liabilities appear on its balance sheet just as if they were the sponsoring firm's assets and liabilities. This is on-balance sheet financing, which largely defeats the purpose of the SPV. For this reason, a sponsoring firm typically takes only a partial ownership position in the SPV. In other arrangements, it takes no ownership interest in the SPV whatsoever.
SPVs are used in a variety of transactions, including securitizations, project finance, and leasing. An SPV can take various legal forms, including corporations, US-style trusts or partnerships.
Off-balance sheet financing is attractive from a risk management standpoint. When assets and liabilities are moved from one balance sheet to another, the risks associated with those assets and liabilities go with them. For example, if a firm transfers credit risky assets to an SPV, the credit risk goes with those assets.
Off-balance sheet financing also affords considerable flexibility in financing. An SPV doesn't utilize the sponsoring firm's credit lines or other financing channels. It is presented to financiers as a stand-alone entity with its own risk-reward characteristics. It can issue its own debt or establish its own lines of credit. Often, a sponsoring firm overcapitalizes an SPV or supplies it with credit enhancement. In this circumstance, the SPV may have a higher credit rating than the sponsoring firm, and it will achieve a lower cost of funding. A BBB-rated firm can achieve AAA-rated financing costs if it arranges that financing through a sufficiently capitalized SPV.
Off-balance sheet financing is often employed as a means of asset-liability management. Obviously, if assets and liabilities are never placed on the balance sheet, they don't have to be matched! They do need to be matched on the SPV's balance sheet, but the SPV can be structured in a way that facilitates this. A pass-through is a security issued by a special purpose vehicle. The SPV holds assets and pays the pass-through's investors whatever net cash flows those assets generate. In this way, the SPV's assets and liabilities are automatically cash matched, so there is no asset-liability risk. Many securitizations are structured as pass-throughs. See, for example, the discussion of mortgage pass-throughs.
Off-balance sheet financing has other applications. SPVs can be used in tax avoidance. Banks use off-balance sheet financing to achieve reductions in their regulatory capital requirements. This is a compelling reason for many securitizations. It is also the purpose of trust preferred securities.
While SPVs and off-balance sheet financing have many legitimate purposes, they can also be used to misrepresent a firm's financial condition. Prior to its bankruptcy, Enron created numerous SPVs and used them to hide billions of dollars in debt. That abuse, as well as other scandals during 2001-2002, prompted a reexamination of SPVs. Laws, regulations and accounting rules were tightened as a result.
hey bid sitters-better move up a couple tiks if you really want those shares
yep mms spliting hairs between .001 and .0011 hehehe
no brainer -so many eyes and everyone has some shares tucked away for fda news. its gonna be great. these shares are hot!
ADMD trading now under control. if we were going lower, shorty would have scooped up them .0006s. them 0006 would be gone. this is a good sign we are moving upward, shares being held tight. patience is needed here, imo
assuming the company still owns at least 51 percent of their a/s that would be 1 billion shares plus. now if just 300 people own 2 million shares thats another 600 million shares. we know a lot of posters here hold a lot more than 2 million shares. plus the reg sho designation-do not believe any real shares out there. naked shorts/air shares only
shares are scarce shorty http://www.otcmarkets.com/market-activity/reg-sho-otc
ADMD about to get real believe. getting excited for this one. expecting FDA news, believe they will get approved, but before announcing approval, think we will see some more news regarding finance/partnership/commercialization plans first, then fda news, we shall see GLTA
over 3 million shares traded after the bell yesterday as well. heavy accum here. looking good
rumors of copper here, are well founded. very exciting times. those with a little patience and emotional control will be well rewarded in my opinion.
take a peek at our medical advisory board member Dr Fishers creds-
with patent, industry experts, and a license for world wide distribution, i believe ADMD is on the right track and will succeed -all the naysayers must remember-- Advanced Medical Isotope Corporation is a late stage development company
any development stage company is a gamble- so if you dont want to gamble you should move on to somthing that makes you feel warm, safe, and fuzzy-good luck
https://www.linkedin.com/pub/darrell-r-fisher/13/357/932
principal medical dosimetrist; medical physicist
Dade Moeller Health Group, Richland, Washington
July 2013 – Present (1 year 5 months)Richland/Kennewick/Pasco, Washington Area
Dr. Darrell R. Fisher is principal medical dosimetrist at Dade Moeller Health Group in Richland, Washington. Concurrently, he serves as president of the Health Physics Society, an international association of scientists and engineers dedicated to radiation safety. Previously, Dr. Fisher led the Isotope Sciences Research Program at Pacific Northwest National Laboratory in Richland, Washington, where his responsibilities included medical and industrial isotopes research and applications, new radiopharmaceutical design and testing, and internal radiation dosimetry. He developed yttrium-90 radiogels and tissue adhesives for direct intumoral radiation therapy. He also invented a next-generation brachytherapy seed for controlled delivery of yttrium-90 microspheres--recently licensed to Advanced Medical Isotope Corporation, Kennewick, for world-wide distribution. His recent work involved design and testing of non-toxic nanoparticle constructs for delivery of radioisotopes to cancer cells. Dr. Fisher is an authority on the dosimetry and biological effects of medically administered radiopharmaceuticals. He is a member of the Society of Nuclear Medicine and Molecular Imaging's special committee on Medical Internal Radiation Dose (MIRD). He served on the Nuclear Regulatory Commission's Advisory Committee on the Medical Uses of Isotopes (ACMUI). He teaches radiological physics and technical writing at Washington State University. He is an affiliate associate professor of radiology at the University of Washington School of Medicine in Seattle, where he supports the Division of Nuclear Medicine. He previously served a two-year assignment as science advisor at U.S. Customs and Border Protection in Washington, DC.
CHS1,luis33,bill b123- everyone is aware of the equity financing with ADMD. seems note holders believe in the company when they agree to accept shares as collateral on the notes. short volume tells the tale here. there is not enough short volume to support all your bashing. ADMD has been upfront from the start,all one has to do is read the filings. i suspect CHS1,luis33,bill b123 are scooping up these cheap shares. its obvious with the volume as of late. every share that is sold there is a buyer, even if the shares are convertible from notes or not. IMO shareholders are here for FDA clearance NEWS! when that happens, i will be very happy with my position here. CHS1,luis33,bill b123-your AGENDA here is very clear to everyone, acutually i welcome your bashing because it allows me to get cheaper shares. lol. CHS1,luis33,bill b123- you all argue that the company is taking money from investor/shareholders. what do you all think "equity financing is for? people invest in companies because they believe in the future of the company. investors are willing to give their money to the company so it can succeed-DUH! seems there would be 100's of millions of shares short if what CHS1,luis33,bill b123 are posting is true. everyone already knows about the convertible notes and the A/S increase. everything is in the company filings for the world to see. Yet, we still have buyers of large block shares. Hmmm?
When it comes to funding a small business, there are two basic options: debt or equity financing.
Each has its advantages and drawbacks, so it’s important to know a bit about both so you can make the best decision for financing your business.
Debt Financing
Debt financing involves borrowing money, typically in the form of a loan from a bank or other financial institution or from commercial finance companies, to fund your business.
Getting a business loan generally requires good credit and solid financials, as well as collateral for larger loans.
Many small business owners are afraid to take on debt because they fear they may not have the cash flow to repay the debt (plus interest) in a timely fashion.
Others may be concerned that they don’t have the credit-worthiness to get a bank loan, and so don’t want to even bother applying.
But debt financing has some definite advantages that make it an option worth considering for any small business owner.
First and foremost, unlike with equity financing, debt financing allows you to retain control of your business, as ownership stays fully in your hands.
You may have to back up a loan with collateral, so if you default you may lose certain tangible assets, but you won’t lose creative and strategic control of your business.
In addition, taking on debt can build your business credit, which is good for future borrowing and for insurance rates.
It’s also worth bearing in mind that interest paid on loans is tax deductible, softening the blow of repayment somewhat.
Equity Financing
Equity financing involves bringing in investors or partners who provide capital in exchange for a share of ownership of the business.
These investors or partners generally invest because they expect to make a profit when the business becomes successful.
Unlike a loan, if you don’t make a profit, you usually aren’t required to pay them back. The absence of monthly loan payments can free up significant working capital for the business.
Many small business owners also are drawn to equity financing because, while investors or partners will only provide equity if they have faith in the earning power of your business, you don’t necessarily need the pristine financial history that is required for a loan.
This can be a crucial point for many small business owners, especially for those just starting a business without the two or three years of financials most banks look at.
The cost of these benefits is that you no longer retain sole control of your business.
This means that not only will your investors be entitled to a share of profits, but they also have a say in the running of your business and the direction it’s headed.
This may not seem like a problem at the beginning when you need cash, but can sometimes lead to conflict further down the road.
On the other hand, a strong, smart partner may be an asset to your business; especially if you find someone who is a good compliment to yourself.
If you’re the creative, visionary type, you may benefit from the balancing influence of a partner who is grounded and pennywise.
The Bottom Line
Because each type of financing has its own appeal, businesses often take advantage of both debt and equity financing, utilizing each to its best advantage.
Look at the benefits of each to see which may most help your business, and compare typical debt-to-equity ratios for other businesses in your industry when deciding what type of financing to seek.https://www.mint.com/blog/consumer-iq/the-difference-between-debt-and-equity-financing-for-your-small-business-0613/
I do not believe ADMD would be involved with any funny business.
Look at ADMD CFO credentials----------------------------------------------------------------------
Leonard Bruce Jolliff
Chief Financial Officer
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMIC’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
one only need to look to our managements credentials, partners, advisory board members, etc. there will be no games here, the cfo wont allow it. company has been up front from the start. waiting for a major news event, after that revs can flow and only increase IMO.
looking good! 8k should be out today. share price going up with the A/S increase is a good sign imo. dont see any dumping.
share price held up well with the yes vote. 8k out tomorrow per phone call to company this afternoon.
imo more than likely it will happen, there is a chance it does not happen, either way there has been buying interest even with the knowledge of potential A/S increase. insiders control the company and own some of the conv notes. appears A/S increase already factored in pps imo. maybe the O/S doesnt increase but A/S does, thats a possibility?
well then short the hell out of it, i dare you!
idk but rumor is that there are several investors in this stock-i heard microsoft,nike,ali baba,coke,apple, warren buffet, and the ebola virus took sizable positions here. lol jk
shoot idk whats you guess? wink wink
low volume support,havnt seen any major dumping- huge vol on bid, short volume has dried up-lowest its been in 1.5 months, still on reg sho list. over issued shares, and possible A/S increase, insider ownership. add it up folks, if those in the know thought this was going to tank i believe the short position would be huge. everyone in this is hoping it hits trips so we can load up-usually i want pps to go up, but on this i want some more cheapies-you all know you do too, hence the huge numbers on the bid the last few days.;)
AMIC is in the process of securing FDA approval for its Y-90 RadioGel(TM) brachytherapy device. As AMIC recently announced, the FDA has determined that the RadioGel(TM) brachytherapy product is a Class III medical device, unless reclassified as a Class II device.
were waiting on class II fda approval news-when that happens, the shares available at pps now are gonna look VERY GOOD!
-with the 100mill share structure we reached high of .29 not .125 i was using 52week numbers for example i posted earlier and i see your point about the share structure-but with that 100mill ss we did reach $.29 pps. max O/S can only be approx 1.3 bill if they vote to increase A/S t0 2bill. if they had to pay off all of the conv notes today the total is approx $560,000. it appears that most of the notes are held by insiders. insiders are financing their own company-making 10 percent on their money(smart money)- why let other people get the interest on the notes when you can recoup it yourself and secure the note with something they already own. imo- i see 5x bagger at these pps with fully diluted share structure-if we get news or no increase in SS, pps will increase mucho grande. they have created there own revolving credit line with insiders holding notes. why would the company want to shut themselves down? wouldnt make sense. they could forgive themselves the debt if need be.
dilution not that big, if it happens- plus dilution already priced in at these levels imo- check my prev posts. max O/S can only be about 1.3bill shares if they vote to increase A/S to 2bill. if share price goes lower i will scoop some more....